San Guo

Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report

Siyuan Huang, Sanxing Guo, Hui Zhang, 2022, Frontiers in Pharmacology.